US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

1.94

+0.180010.23%

Post-market: 1.92-0.0192-0.99%19:52 EDT

Volume:717.96K

Turnover:1.41M

Market Cap:2.88M

PE:-0.01

High:2.10

Open:1.82

Low:1.81

Close:1.76

52wk High:524.00

52wk Low:1.43

Shares:1.49M

Float Shares:1.48M

Volume Ratio:13.39

T/O Rate:48.64%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-175.9200

EPS(LYR):-303.4772

ROE:-114.61%

ROA:-51.35%

PB:0.25

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Clearmind Medicine Announces “Inside Meai” Webinar Featuring New Insights From Cmnd-100 Psychedelic Clinical Trial

THOMSON REUTERS

BRIEF-Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of Ptsd

Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of Ptsd

THOMSON REUTERS

Clearmind names Hila Kiron-Revach board chair after Amitay Weiss steps down

Clearmind evaluates MEAI for FDA breakthrough therapy designation in alcohol use disorder trial

Clearmind Medicine Inc - Has Not Submitted or Received FDA Breakthrough Therapy Designation for Meai

THOMSON REUTERS

Clearmind Medicine issues $2.7 million convertible notes at 10% discount

Clearmind welcomes Trump executive order speeding FDA review of breakthrough psychedelic therapies

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Clearmind says CMND-100 meets primary safety endpoint in AUD Phase I/IIa trial

Clearmind Medicine Inc - Cmnd-100 Shows High Safety Profile at Highest Dosage With No Serious Adverse Events

THOMSON REUTERS

Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial

Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial

Clearmind announces DSMB recommendation to continue CMND-100 trial

Clearmind advances CMND-100 alcohol use disorder trial, raises dose to 160 mg

Clearmind Medicine Inc - Cmnd-100 Well Tolerated With No Serious Adverse Events in Third Cohort

THOMSON REUTERS

Clearmind Medicine Inc - to Proceed to Fourth Cohort, Increase Cmnd-100 Dose to 160Mg

THOMSON REUTERS

Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in Ongoing Cmnd-100 Clinical Trial

THOMSON REUTERS

Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial

Clearmind Medicine issues $1.75 million convertible notes, raises $1.58 million cash

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/CMND/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","market":"US","secType":"STK","nameCN":"Clearmind Medicine, Inc.","latestPrice":1.94,"timestamp":1788206400000,"preClose":1.76,"halted":0,"volume":717963,"hourTrading":{"tag":"盘后","latestPrice":1.9208,"preClose":1.94,"latestTime":"19:52 EDT","volume":11225,"amount":21598.2315,"timestamp":1788220347382,"change":-0.0192,"changeRate":-0.009897,"amplitude":0.020619},"delay":0,"changeRate":0.10227272727272724,"floatShares":1475956,"shares":1485551,"eps":-175.92,"marketStatus":"Closed","change":0.18,"latestTime":"08-31 16:00:00 EDT","open":1.82,"high":2.1,"low":1.81,"amount":1413663.4750923,"amplitude":0.164773,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-175.92,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"listingDate":1668142800000,"exchange":"NASDAQ","adjPreClose":1.76,"preHourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.76,"latestTime":"08:53 EDT","volume":2351,"amount":4287.1408943,"timestamp":1788180829939,"change":0.04,"changeRate":0.022727,"amplitude":0.039773},"postHourTrading":{"tag":"盘后","latestPrice":1.9208,"preClose":1.94,"latestTime":"19:52 EDT","volume":11225,"amount":21598.2315,"timestamp":1788220347382,"change":-0.0192,"changeRate":-0.009897,"amplitude":0.020619},"volumeRatio":13.388288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","floatShares":1475956,"roa":"-51.35%","roe":"-114.61%","lyrEps":-303.47721,"volumeRatio":13.388288,"shares":1485551,"dividePrice":0,"high":2.1,"amplitude":0.164773,"preClose":1.76,"low":1.81,"week52Low":1.43,"pbRate":"0.25","week52High":524,"institutionHeld":0,"latestPrice":1.94,"eps":-175.92,"divideRate":0,"volume":717963,"delay":0,"ttmEps":-175.92,"open":1.82,"prevYearClose":18.1,"prevWeekClose":1.76,"prevMonthClose":1.69,"prevQuarterClose":2.2,"fiveDayClose":1.68,"twentyDayClose":1.63,"sixtyDayClose":2.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-21","symbol":"CMND","defaultRemindTime":1779370200000,"type":"split","dateTimestamp":1779336000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-12-15","symbol":"CMND","defaultRemindTime":1765809000000,"type":"split","dateTimestamp":1765774800000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-11-28","symbol":"CMND","defaultRemindTime":1701181800000,"type":"split","dateTimestamp":1701147600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMND","date":"2026-08-28","current":-0.011028,"percent":0.925714,"low":-79.538912,"twenty":-1.471776,"median":-0.912941,"eighty":-0.467711,"high":-0.132425,"avg":-3.435012,"sd":10.190595,"marketCap":2688847},"quantilePoints":[{"date":"2021-09-03","current":-77.809807,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":26985610.07},{"date":"2021-09-10","current":-70.893378,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24346632.12},{"date":"2021-09-17","current":-71.757932,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24430331.48},{"date":"2021-09-24","current":-73.487039,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":25125635.9},{"date":"2021-10-01","current":-18.935815,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24276713.03},{"date":"2021-10-08","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23471549.77},{"date":"2021-10-15","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23660527.38},{"date":"2021-10-22","current":-17.781192,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23366442.66},{"date":"2021-10-29","current":-16.626569,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":21791515.03},{"date":"2021-11-05","current":-17.319343,"twenty":-61.834695,"median":-18.935815,"eighty":-5.327909,"marketCap":22614497.39},{"date":"2021-11-12","current":-16.16472,"twenty":-61.834695,"median":-18.473966,"eighty":-5.327909,"marketCap":20907283.62},{"date":"2021-11-19","current":-15.933796,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":20493935.46},{"date":"2021-11-26","current":-17.319343,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":22007930.87},{"date":"2021-12-03","current":-16.16472,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20516830.56},{"date":"2021-12-10","current":-15.933796,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20363701.64},{"date":"2021-12-17","current":-14.548248,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":18448575.82},{"date":"2021-12-23","current":-13.393625,"twenty":-61.834695,"median":-17.781192,"eighty":-5.327909,"marketCap":16986524.41},{"date":"2021-12-31","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17198471.74},{"date":"2022-01-07","current":-12.700852,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16298591.95},{"date":"2022-01-14","current":-12.239002,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":15851627.15},{"date":"2022-01-21","current":-10.853455,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14077636.85},{"date":"2022-01-28","current":-12.931776,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16468260.15},{"date":"2022-02-04","current":-14.548248,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18518085.11},{"date":"2022-02-11","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18343985.21},{"date":"2022-02-18","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18253458.39},{"date":"2022-02-25","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17082383.51},{"date":"2022-03-04","current":-4.943147,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14402278.55},{"date":"2022-03-11","current":-4.741385,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":13870054.34},{"date":"2022-03-18","current":-4.489184,"twenty":-61.834695,"median":-17.582743,"eighty":-5.327909,"marketCap":13226105.9},{"date":"2022-03-25","current":-2.663476,"twenty":-61.834695,"median":-17.550268,"eighty":-5.327909,"marketCap":12172123.95},{"date":"2022-04-01","current":-2.696359,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":12315499.88},{"date":"2022-04-08","current":-3.090948,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":14024131.41},{"date":"2022-04-14","current":-2.433299,"twenty":-61.834695,"median":-17.088418,"eighty":-5.327909,"marketCap":11016821.23},{"date":"2022-04-22","current":-2.30177,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":10351738.45},{"date":"2022-04-29","current":-2.564829,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":11431112.19},{"date":"2022-05-06","current":-2.531947,"twenty":-61.834695,"median":-16.511107,"eighty":-5.327909,"marketCap":11240443.79},{"date":"2022-05-13","current":-2.433299,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10747956.2},{"date":"2022-05-20","current":-2.466182,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10972362.04},{"date":"2022-05-27","current":-2.334652,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10462796.86},{"date":"2022-06-03","current":-2.400417,"twenty":-61.834695,"median":-15.933796,"eighty":-5.327909,"marketCap":10896966.45},{"date":"2022-06-10","current":-2.30177,"twenty":-61.834695,"median":-15.702871,"eighty":-5.327909,"marketCap":10273199.15},{"date":"2022-06-17","current":-2.400417,"twenty":-61.834695,"median":-15.471947,"eighty":-5.327909,"marketCap":10503138.41},{"date":"2022-06-24","current":-2.367534,"twenty":-61.744414,"median":-15.471947,"eighty":-5.327909,"marketCap":10469452.66},{"date":"2022-07-01","current":-1.560974,"twenty":-60.553176,"median":-15.147663,"eighty":-5.327909,"marketCap":10729626.02},{"date":"2022-07-08","current":-1.560974,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10710469.08},{"date":"2022-07-15","current":-1.605574,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10950633.46},{"date":"2022-07-22","current":-1.516375,"twenty":-57.130437,"median":-15.147663,"eighty":-5.327909,"marketCap":10468944.81},{"date":"2022-07-29","current":-1.427176,"twenty":-56.195971,"median":-15.147663,"eighty":-5.327909,"marketCap":9885259.74},{"date":"2022-08-05","current":-1.471776,"twenty":-55.226088,"median":-14.779173,"eighty":-5.327909,"marketCap":10092669.27},{"date":"2022-08-12","current":-1.427176,"twenty":-54.0772,"median":-14.548248,"eighty":-5.327909,"marketCap":9901792.86},{"date":"2022-08-19","current":-1.427176,"twenty":-43.677709,"median":-14.317323,"eighty":-5.327909,"marketCap":9745576.64},{"date":"2022-08-26","current":-1.382577,"twenty":-41.597849,"median":-14.317323,"eighty":-5.327909,"marketCap":9442770.76},{"date":"2022-09-02","current":-1.271079,"twenty":-41.597849,"median":-14.086399,"eighty":-5.327909,"marketCap":8615042.98},{"date":"2022-09-09","current":-1.427176,"twenty":-41.597849,"median":-14.086399,"eighty":-5.135307,"marketCap":9711214.67},{"date":"2022-09-16","current":-1.360278,"twenty":-41.597849,"median":-13.855475,"eighty":-5.135307,"marketCap":9096403.07},{"date":"2022-09-23","current":-1.248779,"twenty":-41.597849,"median":-13.62455,"eighty":-5.135307,"marketCap":8172150.47},{"date":"2022-09-30","current":-0.929266,"twenty":-41.597849,"median":-13.393625,"eighty":-5.135307,"marketCap":6512507.37},{"date":"2022-10-07","current":-1.087585,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7646662.48},{"date":"2022-10-14","current":-1.080702,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7496705.29},{"date":"2022-10-21","current":-1.049293,"twenty":-41.597849,"median":-13.278163,"eighty":-5.074202,"marketCap":7357917.44},{"date":"2022-10-28","current":-1.165881,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":8234273.61},{"date":"2022-11-04","current":-1.08907,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":7753472.39},{"date":"2022-11-11","current":-1.082212,"twenty":-38.270012,"median":-12.931776,"eighty":-5.074202,"marketCap":7833552.75},{"date":"2022-11-18","current":-1.935818,"twenty":-37.438053,"median":-12.700852,"eighty":-5.074202,"marketCap":13927482.09},{"date":"2022-11-25","current":-1.650458,"twenty":-37.438053,"median":-12.585389,"eighty":-5.074202,"marketCap":11873272.72},{"date":"2022-12-02","current":-1.27255,"twenty":-37.438053,"median":-12.008078,"eighty":-5.074202,"marketCap":9091614.07},{"date":"2022-12-09","current":-1.079739,"twenty":-37.438053,"median":-11.682462,"eighty":-4.943147,"marketCap":7625598.02},{"date":"2022-12-16","current":-1.40109,"twenty":-37.438053,"median":-11.587771,"eighty":-4.791826,"marketCap":9845331.19},{"date":"2022-12-23","current":-1.375382,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":9740512.57},{"date":"2022-12-30","current":-1.141438,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":8114893.38},{"date":"2023-01-06","current":-1.118301,"twenty":-37.438053,"median":-11.587771,"eighty":-4.539624,"marketCap":7989125.08},{"date":"2023-01-13","current":-1.62475,"twenty":-37.438053,"median":-11.587771,"eighty":-4.186477,"marketCap":11656520.47},{"date":"2023-01-20","current":-1.568192,"twenty":-37.438053,"median":-10.853455,"eighty":-4.136102,"marketCap":11253776.1},{"date":"2023-01-27","current":-1.33682,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9661985.46},{"date":"2023-02-03","current":-1.332642,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9371651.68},{"date":"2023-02-10","current":-1.393097,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9812413.93},{"date":"2023-02-17","current":-1.272187,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8867258.2},{"date":"2023-02-24","current":-1.240431,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8572078.87},{"date":"2023-03-03","current":-1.10085,"twenty":-37.438053,"median":-9.227851,"eighty":-3.551938,"marketCap":7606207.65},{"date":"2023-03-10","current":-1.198293,"twenty":-37.438053,"median":-9.227851,"eighty":-3.45974,"marketCap":8185550.86},{"date":"2023-03-17","current":-1.120516,"twenty":-37.438053,"median":-9.227851,"eighty":-2.755547,"marketCap":7980631.72},{"date":"2023-03-24","current":-0.916786,"twenty":-37.438053,"median":-9.227851,"eighty":-2.696359,"marketCap":6519731.67},{"date":"2023-03-31","current":-0.417647,"twenty":-37.438053,"median":-9.227851,"eighty":-2.624017,"marketCap":3018701.27},{"date":"2023-04-06","current":-0.132425,"twenty":-37.438053,"median":-9.227851,"eighty":-2.584558,"marketCap":960449.73},{"date":"2023-04-14","current":-0.500779,"twenty":-37.438053,"median":-9.227851,"eighty":-2.531947,"marketCap":3666478.25},{"date":"2023-04-21","current":-0.622397,"twenty":-37.438053,"median":-9.227851,"eighty":-2.499064,"marketCap":4520895.91},{"date":"2023-04-28","current":-0.579473,"twenty":-37.438053,"median":-9.227851,"eighty":-2.453029,"marketCap":4166925.01},{"date":"2023-05-05","current":-0.550857,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":3966371.91},{"date":"2023-05-12","current":-0.558011,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":4046484.45},{"date":"2023-05-19","current":-0.572319,"twenty":-37.438053,"median":-9.227851,"eighty":-2.400417,"marketCap":4145445.66},{"date":"2023-05-26","current":-0.58694,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":4210059.56},{"date":"2023-06-02","current":-0.550709,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":3999105.96},{"date":"2023-06-09","current":-0.514478,"twenty":-34.942175,"median":-9.227851,"eighty":-2.321499,"marketCap":3767591.98},{"date":"2023-06-16","current":-0.531091,"twenty":-33.278257,"median":-9.227851,"eighty":-2.30177,"marketCap":3748293.76},{"date":"2023-06-23","current":-0.458354,"twenty":-33.278257,"median":-9.227851,"eighty":-2.28204,"marketCap":3234938.84},{"date":"2023-06-30","current":-0.478478,"twenty":-30.295333,"median":-9.227851,"eighty":-2.043589,"marketCap":3376966.22},{"date":"2023-07-07","current":-0.436578,"twenty":-26.688751,"median":-9.227851,"eighty":-1.802136,"marketCap":3081249.21},{"date":"2023-07-14","current":-0.436972,"twenty":-26.688751,"median":-8.613576,"eighty":-1.651163,"marketCap":3084034.14},{"date":"2023-07-21","current":-0.43717,"twenty":-26.688751,"median":-8.613576,"eighty":-1.562418,"marketCap":3085429.18},{"date":"2023-07-28","current":-0.458608,"twenty":-26.688751,"median":-8.613576,"eighty":-1.560974,"marketCap":3236727.75},{"date":"2023-08-04","current":-0.483799,"twenty":-26.688751,"median":-8.613576,"eighty":-1.558522,"marketCap":3414522.56},{"date":"2023-08-11","current":-0.383836,"twenty":-26.688751,"median":-6.222948,"eighty":-1.516375,"marketCap":2709008.42},{"date":"2023-08-18","current":-0.372906,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2631871.39},{"date":"2023-08-25","current":-0.39406,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2781166.24},{"date":"2023-09-01","current":-0.447028,"twenty":-26.688751,"median":-5.926622,"eighty":-1.427176,"marketCap":3155002.59},{"date":"2023-09-08","current":-0.442472,"twenty":-19.813329,"median":-5.926622,"eighty":-1.427176,"marketCap":3122844.46},{"date":"2023-09-15","current":-0.187109,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":1320569.3},{"date":"2023-09-22","current":-0.388305,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":2475737.22},{"date":"2023-09-29","current":-0.315336,"twenty":-19.430851,"median":-5.926622,"eighty":-1.415486,"marketCap":2010507.36},{"date":"2023-10-06","current":-0.365327,"twenty":-19.430851,"median":-5.926622,"eighty":-1.395726,"marketCap":2329231.67},{"date":"2023-10-13","current":-0.367265,"twenty":-19.430851,"median":-5.926622,"eighty":-1.382577,"marketCap":2341589.46},{"date":"2023-10-20","current":-0.334674,"twenty":-19.430851,"median":-5.926622,"eighty":-1.368527,"marketCap":2133796.18},{"date":"2023-10-27","current":-0.290523,"twenty":-19.430851,"median":-5.926622,"eighty":-1.366813,"marketCap":1852300.65},{"date":"2023-11-03","current":-0.316281,"twenty":-19.430851,"median":-5.926622,"eighty":-1.360278,"marketCap":2016523.46},{"date":"2023-11-10","current":-0.325261,"twenty":-19.430851,"median":-5.390754,"eighty":-1.337978,"marketCap":2073784.82},{"date":"2023-11-17","current":-0.300361,"twenty":-19.430851,"median":-5.330934,"eighty":-1.337515,"marketCap":1915028.46},{"date":"2023-11-24","current":-0.302508,"twenty":-19.430851,"median":-5.327909,"eighty":-1.335149,"marketCap":1928712.73},{"date":"2023-12-01","current":-0.350938,"twenty":-19.430851,"median":-5.327909,"eighty":-1.296306,"marketCap":2237493.37},{"date":"2023-12-08","current":-0.980569,"twenty":-19.430851,"median":-5.327909,"eighty":-1.274244,"marketCap":6251864.25},{"date":"2023-12-15","current":-0.736628,"twenty":-19.430851,"median":-5.327909,"eighty":-1.271301,"marketCap":4696557.28},{"date":"2023-12-22","current":-0.812759,"twenty":-19.430851,"median":-5.327909,"eighty":-1.259672,"marketCap":5181946.56},{"date":"2023-12-29","current":-0.682126,"twenty":-19.430851,"median":-5.327909,"eighty":-1.237797,"marketCap":4349066.88},{"date":"2024-01-05","current":-0.630384,"twenty":-19.430851,"median":-5.327909,"eighty":-1.211461,"marketCap":4019166.25},{"date":"2024-01-12","current":-0.436686,"twenty":-19.430851,"median":-5.327909,"eighty":-1.179486,"marketCap":2784200.42},{"date":"2024-01-19","current":-0.561866,"twenty":-19.430851,"median":-5.327909,"eighty":-1.15795,"marketCap":3582314.16},{"date":"2024-01-26","current":-0.716167,"twenty":-19.430851,"median":-5.327909,"eighty":-1.132962,"marketCap":4566100.74},{"date":"2024-02-02","current":-0.652747,"twenty":-19.430851,"median":-5.327909,"eighty":-1.116775,"marketCap":5627224.65},{"date":"2024-02-09","current":-0.504935,"twenty":-19.430851,"median":-5.327909,"eighty":-1.1005,"marketCap":4352964.23},{"date":"2024-02-16","current":-0.519849,"twenty":-19.430851,"median":-5.327909,"eighty":-1.096168,"marketCap":4481532.37},{"date":"2024-02-23","current":-0.672729,"twenty":-18.473966,"median":-5.327909,"eighty":-1.087585,"marketCap":5799482.19},{"date":"2024-03-01","current":-0.54179,"twenty":-18.473966,"median":-5.327909,"eighty":-1.08191,"marketCap":4670679.77},{"date":"2024-03-08","current":-0.505134,"twenty":-18.473966,"median":-5.327909,"eighty":-1.079739,"marketCap":4354677.58},{"date":"2024-03-15","current":-0.435211,"twenty":-18.473966,"median":-5.327909,"eighty":-1.064778,"marketCap":3751886.19},{"date":"2024-03-22","current":-0.499967,"twenty":-18.473966,"median":-5.327909,"eighty":-1.046318,"marketCap":4044318},{"date":"2024-03-28","current":-0.471743,"twenty":-18.473966,"median":-5.327909,"eighty":-0.975962,"marketCap":3816009},{"date":"2024-04-05","current":-0.463679,"twenty":-18.473966,"median":-5.327909,"eighty":-0.890377,"marketCap":3750779},{"date":"2024-04-12","current":-0.516095,"twenty":-18.473966,"median":-5.327909,"eighty":-0.810049,"marketCap":4174780},{"date":"2024-04-19","current":-0.475009,"twenty":-18.473966,"median":-5.327909,"eighty":-0.7392,"marketCap":3842428},{"date":"2024-04-26","current":-0.483839,"twenty":-18.473966,"median":-5.327909,"eighty":-0.711567,"marketCap":3913856},{"date":"2024-05-03","current":-0.471784,"twenty":-18.473966,"median":-5.327909,"eighty":-0.652729,"marketCap":3816336},{"date":"2024-05-10","current":-0.604799,"twenty":-18.473966,"median":-5.327909,"eighty":-0.644215,"marketCap":4892320},{"date":"2024-05-17","current":-0.520127,"twenty":-18.473966,"median":-5.327909,"eighty":-0.61393,"marketCap":4207395},{"date":"2024-05-24","current":-0.453599,"twenty":-18.473966,"median":-5.327909,"eighty":-0.600881,"marketCap":3669240},{"date":"2024-05-31","current":-0.459647,"twenty":-18.473966,"median":-5.327909,"eighty":-0.594105,"marketCap":3718163},{"date":"2024-06-07","current":-0.420053,"twenty":-18.473966,"median":-5.109555,"eighty":-0.586092,"marketCap":3397879},{"date":"2024-06-14","current":-0.435455,"twenty":-18.473966,"median":-5.074202,"eighty":-0.577013,"marketCap":3522470},{"date":"2024-06-21","current":-0.612279,"twenty":-18.473966,"median":-5.074202,"eighty":-0.572319,"marketCap":4237588},{"date":"2024-06-28","current":-0.64098,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":4436225},{"date":"2024-07-05","current":-0.727082,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5032136},{"date":"2024-07-12","current":-0.770133,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5330091},{"date":"2024-07-15","current":-0.813184,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5628047},{"date":"2024-08-02","current":-0.717515,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":4965924},{"date":"2024-08-09","current":-0.569229,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":3939633},{"date":"2024-08-16","current":-0.545311,"twenty":-19.331844,"median":-5.074202,"eighty":-0.558549,"marketCap":3774102},{"date":"2024-08-23","current":-0.660114,"twenty":-19.331844,"median":-5.008674,"eighty":-0.558011,"marketCap":4568650},{"date":"2024-08-30","current":-0.631413,"twenty":-19.331844,"median":-4.791826,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-06","current":-0.617063,"twenty":-19.331844,"median":-4.539624,"eighty":-0.558011,"marketCap":4270694},{"date":"2024-09-13","current":-0.631413,"twenty":-19.331844,"median":-4.09773,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-20","current":-0.506022,"twenty":-19.331844,"median":-4.059359,"eighty":-0.552636,"marketCap":4270694},{"date":"2024-09-27","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-04","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-11","current":-0.653648,"twenty":-19.331844,"median":-4.04729,"eighty":-0.550947,"marketCap":5516615},{"date":"2024-10-18","current":-0.634423,"twenty":-19.331844,"median":-2.811447,"eighty":-0.550947,"marketCap":5354362},{"date":"2024-10-25","current":-0.74016,"twenty":-19.331844,"median":-2.696359,"eighty":-0.550947,"marketCap":6246755},{"date":"2024-10-31","current":-0.70171,"twenty":-19.331844,"median":-2.614152,"eighty":-0.550947,"marketCap":5922249},{"date":"2024-11-08","current":-0.672873,"twenty":-19.430851,"median":-2.531947,"eighty":-0.550857,"marketCap":5678869},{"date":"2024-11-15","current":-0.706517,"twenty":-19.430851,"median":-2.499064,"eighty":-0.550857,"marketCap":5962812},{"date":"2024-11-22","current":-0.644036,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5435488},{"date":"2024-11-29","current":-0.624811,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5273235},{"date":"2024-12-06","current":-0.639229,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5394925},{"date":"2024-12-13","current":-0.70171,"twenty":-19.430851,"median":-2.400417,"eighty":-0.550857,"marketCap":5922249},{"date":"2024-12-20","current":-0.571942,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":4827038},{"date":"2024-12-27","current":-0.749773,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":6327882},{"date":"2025-01-03","current":-0.696904,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5881685},{"date":"2025-01-10","current":-0.692098,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5841122},{"date":"2025-01-17","current":-0.730548,"twenty":-19.430851,"median":-2.153798,"eighty":-0.550857,"marketCap":6165629},{"date":"2025-01-24","current":-1.150202,"twenty":-19.430851,"median":-1.874119,"eighty":-0.550857,"marketCap":6043939},{"date":"2025-01-31","current":-1.042129,"twenty":-19.430851,"median":-1.662503,"eighty":-0.550857,"marketCap":5476052},{"date":"2025-02-07","current":-1.160721,"twenty":-19.430851,"median":-1.581046,"eighty":-0.550857,"marketCap":6099215},{"date":"2025-02-14","current":-1.13637,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5971260},{"date":"2025-02-21","current":-1.038967,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5459438},{"date":"2025-02-28","current":-0.990265,"twenty":-19.430851,"median":-1.541199,"eighty":-0.550857,"marketCap":5203526},{"date":"2025-03-07","current":-0.900979,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4734356},{"date":"2025-03-14","current":-0.917213,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4819660},{"date":"2025-03-21","current":-1.211596,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":6007699},{"date":"2025-03-28","current":-1.08733,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-04-04","current":-1.066619,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-04-11","current":-0.966947,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":4794606},{"date":"2025-04-17","current":-1.004486,"twenty":-19.430851,"median":-1.424416,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-04-25","current":-1.014841,"twenty":-19.430851,"median":-1.40109,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-05-02","current":-1.056263,"twenty":-19.430851,"median":-1.382577,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-05-09","current":-1.011735,"twenty":-19.430851,"median":-1.375382,"eighty":-0.550857,"marketCap":5016685},{"date":"2025-05-16","current":-1.004486,"twenty":-19.430851,"median":-1.366813,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-05-23","current":-1.035552,"twenty":-19.430851,"median":-1.360278,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-05-30","current":-1.001379,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4965338},{"date":"2025-06-06","current":-0.973316,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4826185},{"date":"2025-06-13","current":-0.909542,"twenty":-19.430851,"median":-1.332642,"eighty":-0.550857,"marketCap":4396917},{"date":"2025-06-20","current":-0.913472,"twenty":-19.430851,"median":-1.295818,"eighty":-0.550857,"marketCap":4415915},{"date":"2025-06-27","current":-0.936415,"twenty":-19.430851,"median":-1.273609,"eighty":-0.550857,"marketCap":4526827},{"date":"2025-07-03","current":-1.168394,"twenty":-19.430851,"median":-1.261673,"eighty":-0.550857,"marketCap":5648264},{"date":"2025-07-11","current":-1.040933,"twenty":-19.430851,"median":-1.240431,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-07-18","current":-1.072798,"twenty":-18.473966,"median":-1.211461,"eighty":-0.550857,"marketCap":5186133},{"date":"2025-07-25","current":-1.094042,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-08-01","current":-1.062177,"twenty":-18.012117,"median":-1.178715,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-08","current":-1.08342,"twenty":-17.781192,"median":-1.163301,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-15","current":-1.08342,"twenty":-17.615217,"median":-1.153532,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-22","current":-1.062177,"twenty":-17.615217,"median":-1.142724,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-29","current":-1.08342,"twenty":-17.615217,"median":-1.133121,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-09-05","current":-1.083951,"twenty":-17.615217,"median":-1.119324,"eighty":-0.550857,"marketCap":5240049},{"date":"2025-09-12","current":-1.115286,"twenty":-17.615217,"median":-1.118135,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-09-19","current":-1.348445,"twenty":-17.589237,"median":-1.118135,"eighty":-0.550857,"marketCap":5466441},{"date":"2025-09-26","current":-1.429352,"twenty":-17.319343,"median":-1.118135,"eighty":-0.550857,"marketCap":5794427},{"date":"2025-10-03","current":-1.375414,"twenty":-16.996048,"median":-1.118135,"eighty":-0.550857,"marketCap":5575769},{"date":"2025-10-10","current":-1.29626,"twenty":-16.765124,"median":-1.118135,"eighty":-0.550857,"marketCap":5254889},{"date":"2025-10-17","current":-1.277382,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5178359},{"date":"2025-10-24","current":-1.324577,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5369684},{"date":"2025-10-31","current":-1.222905,"twenty":-15.610501,"median":-1.118135,"eighty":-0.550857,"marketCap":4957515},{"date":"2025-11-07","current":-0.999602,"twenty":-14.779173,"median":-1.11003,"eighty":-0.550857,"marketCap":4052272},{"date":"2025-11-14","current":-0.466831,"twenty":-14.455878,"median":-1.100951,"eighty":-0.550765,"marketCap":1892481},{"date":"2025-11-21","current":-0.268071,"twenty":-14.224953,"median":-1.099975,"eighty":-0.546197,"marketCap":1086728},{"date":"2025-11-28","current":-0.24222,"twenty":-14.086399,"median":-1.095371,"eighty":-0.543703,"marketCap":981932},{"date":"2025-12-05","current":-0.673835,"twenty":-13.62455,"median":-1.094042,"eighty":-0.543703,"marketCap":2731651},{"date":"2025-12-12","current":-1.06106,"twenty":-13.393625,"median":-1.088758,"eighty":-0.543703,"marketCap":4301415},{"date":"2025-12-19","current":-0.965609,"twenty":-13.162701,"median":-1.087521,"eighty":-0.543703,"marketCap":3914467},{"date":"2025-12-26","current":-0.84722,"twenty":-13.162701,"median":-1.085641,"eighty":-0.543703,"marketCap":3434532},{"date":"2026-01-02","current":-0.669637,"twenty":-12.700852,"median":-1.08342,"eighty":-0.543703,"marketCap":2714630},{"date":"2026-01-09","current":-0.899015,"twenty":-12.146632,"median":-1.08342,"eighty":-0.543703,"marketCap":3644504},{"date":"2026-01-16","current":-0.973008,"twenty":-11.587771,"median":-1.080702,"eighty":-0.543703,"marketCap":3944463},{"date":"2026-01-23","current":-1.049901,"twenty":-11.587771,"median":-1.079739,"eighty":-0.543703,"marketCap":4049449},{"date":"2026-01-30","current":-0.851586,"twenty":-11.587771,"median":-1.073308,"eighty":-0.543703,"marketCap":3284553},{"date":"2026-02-06","current":-0.563836,"twenty":-8.613576,"median":-1.072243,"eighty":-0.543703,"marketCap":2174704},{"date":"2026-02-13","current":-0.423849,"twenty":-8.613576,"median":-1.066619,"eighty":-0.541026,"marketCap":1634777},{"date":"2026-02-20","current":-0.577021,"twenty":-8.613576,"median":-1.066037,"eighty":-0.537847,"marketCap":2225559},{"date":"2026-02-27","current":-0.53514,"twenty":-8.613576,"median":-1.062177,"eighty":-0.536549,"marketCap":2064026},{"date":"2026-03-06","current":-0.502566,"twenty":-8.613576,"median":-1.05906,"eighty":-0.536549,"marketCap":1938390},{"date":"2026-03-13","current":-0.385627,"twenty":-4.943147,"median":-1.056151,"eighty":-0.53281,"marketCap":1487355},{"date":"2026-03-20","current":-0.206114,"twenty":-4.77165,"median":-1.051024,"eighty":-0.530164,"marketCap":1368585},{"date":"2026-03-27","current":-0.231847,"twenty":-4.428656,"median":-1.04883,"eighty":-0.52897,"marketCap":1539450},{"date":"2026-04-02","current":-0.339748,"twenty":-3.99487,"median":-1.046113,"eighty":-0.523835,"marketCap":2255910},{"date":"2026-04-10","current":-0.377498,"twenty":-2.748971,"median":-1.042127,"eighty":-0.520127,"marketCap":2506567},{"date":"2026-04-17","current":-0.262518,"twenty":-2.696359,"median":-1.040933,"eighty":-0.5179,"marketCap":1743108},{"date":"2026-04-24","current":-0.257359,"twenty":-2.597711,"median":-1.035552,"eighty":-0.514478,"marketCap":1708852},{"date":"2026-05-01","current":-0.224108,"twenty":-2.531947,"median":-1.031531,"eighty":-0.511783,"marketCap":1488065},{"date":"2026-05-08","current":-0.86327,"twenty":-2.485911,"median":-1.024161,"eighty":-0.510296,"marketCap":5732064},{"date":"2026-05-15","current":-0.811243,"twenty":-2.433299,"median":-1.014273,"eighty":-0.510296,"marketCap":5386612},{"date":"2026-05-22","current":-0.377536,"twenty":-2.433299,"median":-1.008005,"eighty":-0.505681,"marketCap":2506821},{"date":"2026-05-29","current":-0.376002,"twenty":-2.400417,"median":-1.004486,"eighty":-0.504039,"marketCap":2496630},{"date":"2026-06-05","current":-0.446598,"twenty":-2.367534,"median":-0.999455,"eighty":-0.499967,"marketCap":2965386},{"date":"2026-06-12","current":-0.51259,"twenty":-2.367534,"median":-0.994596,"eighty":-0.498651,"marketCap":3403570},{"date":"2026-06-18","current":-0.404845,"twenty":-2.321499,"median":-0.991077,"eighty":-0.492739,"marketCap":3199763},{"date":"2026-06-26","current":-0.468013,"twenty":-2.30177,"median":-0.980602,"eighty":-0.49207,"marketCap":3699021},{"date":"2026-07-02","current":-0.432301,"twenty":-2.262311,"median":-0.977044,"eighty":-0.488105,"marketCap":3416767},{"date":"2026-07-10","current":-0.389071,"twenty":-1.976951,"median":-0.969308,"eighty":-0.483839,"marketCap":3075090},{"date":"2026-07-17","current":-0.374035,"twenty":-1.699795,"median":-0.957532,"eighty":-0.482232,"marketCap":2956246},{"date":"2026-07-24","current":-0.312009,"twenty":-1.620915,"median":-0.952708,"eighty":-0.478963,"marketCap":2466014},{"date":"2026-07-31","current":-0.30449,"twenty":-1.560974,"median":-0.941592,"eighty":-0.477791,"marketCap":2406592},{"date":"2026-08-07","current":-0.328925,"twenty":-1.560974,"median":-0.934845,"eighty":-0.474646,"marketCap":2599714},{"date":"2026-08-14","current":-0.347721,"twenty":-1.557909,"median":-0.925121,"eighty":-0.472163,"marketCap":2748269},{"date":"2026-08-21","current":-0.325166,"twenty":-1.516375,"median":-0.919213,"eighty":-0.470511,"marketCap":2570003},{"date":"2026-08-28","current":-0.340202,"twenty":-1.471776,"median":-0.912941,"eighty":-0.467711,"marketCap":2688847}],"updateTime":1788233165243},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMND\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634323286","title":"Clearmind Medicine Announces “Inside Meai” Webinar Featuring New Insights From Cmnd-100 Psychedelic Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2634323286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634323286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:55","pubTimestamp":1778500500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA4JXRCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633943966","title":"BRIEF-Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of Ptsd","url":"https://stock-news.laohu8.com/highlight/detail?id=2633943966","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633943966?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:53","pubTimestamp":1777985586,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of PtsdMay 5 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE ANN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633943647","title":"Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of Ptsd","url":"https://stock-news.laohu8.com/highlight/detail?id=2633943647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633943647?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:50","pubTimestamp":1777985451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632610196","title":"Clearmind names Hila Kiron-Revach board chair after Amitay Weiss steps down","url":"https://stock-news.laohu8.com/highlight/detail?id=2632610196","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632610196?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:02","pubTimestamp":1777582943,"startTime":"0","endTime":"0","summary":"Clearmind Medicine said board chair Amitay Weiss resigned effective immediately on April 26, 2026.Directors appointed Asaf Itzhaik to compensation committee plus nominating and corporate governance committee.Audit committee chair role shifted to Itzhaik, with Kiron-Revach plus Yehonatan Shachar also serving.Board classified Kiron-Revach, Shachar plus Itzhaik as independent directors under Nasdaq listing standards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL7vwrM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630128395","title":"Clearmind evaluates MEAI for FDA breakthrough therapy designation in alcohol use disorder trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630128395","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630128395?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:43","pubTimestamp":1777290207,"startTime":"0","endTime":"0","summary":"Clearmind Medicine began evaluating lead candidate CMND-100  for potential FDA Breakthrough Therapy Designation for Alcohol Use Disorder.Positive clinical results have already been presented from its ongoing FDA-approved Phase I/IIa trial, supporting eligibility assessment.Program targets a non-hallucinogenic treatment approach, positioning CMND-100 as a potential new option in a market with limited effective therapies.No Breakthrough Therapy Designation request has been submitted for MEAI, with no FDA designation granted as of April 27, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL3LhkPr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4112","CMND","SG9999014039.USD","IE00BN0W2V16.EUR","BK4007","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","BK4585","BK4588","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395135","title":"Clearmind Medicine Inc - Has Not Submitted or Received FDA Breakthrough Therapy Designation for Meai","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395135?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:41","pubTimestamp":1777290060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA1WN8P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629779252","title":"Clearmind Medicine issues $2.7 million convertible notes at 10% discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2629779252","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629779252?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:18","pubTimestamp":1776719923,"startTime":"0","endTime":"0","summary":"Clearmind Medicine entered agreement on April 20, 2026 to sell convertible promissory notes with aggregate principal amount of USD 2.7 million.Cash purchase price set at 90% of principal, or USD 2.43 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL7ggxL7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629756227","title":"Clearmind welcomes Trump executive order speeding FDA review of breakthrough psychedelic therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2629756227","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629756227?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:03","pubTimestamp":1776715424,"startTime":"0","endTime":"0","summary":"Clearmind welcomed President Donald Trump’s April 18, 2026 executive order directing FDA to prioritize reviews for certain breakthrough-designated psychedelic therapies.Executive order also expands patient access pathways, which Clearmind framed as a catalyst for veteran mental health care.Clearmind highlighted February 2026 bipartisan House bill H.R. 7091 as a milestone that explicitly named its MEAI compound for potential VA-supported trials.Company said it is advancing FDA-authorized Phase I/IIa trials of lead candidate CMND-100 for alcohol use disorder at Yale School of Medicine and Johns Hopkins University.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLTf5rZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","CMND","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","BK4007","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628265087","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2628265087","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628265087?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:34","pubTimestamp":1776692072,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nAQN2LVC04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628422427","title":"Clearmind says CMND-100 meets primary safety endpoint in AUD Phase I/IIa trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628422427","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628422427?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:15","pubTimestamp":1776683722,"startTime":"0","endTime":"0","summary":"Clearmind Medicine reported positive top-line safety results from its FDA-approved Phase I/IIa trial of CMND-100 for Alcohol Use Disorder on April 20, 2026.Data from third cohort showed drug candidate was well tolerated at highest dose tested so far, with no serious adverse events reported.Study met its primary endpoint on safety and tolerability, supporting continued development of CMND-100 as a potential non-hallucinogenic oral treatment option for Alcohol Use Disorder.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL6T4625:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014039.USD","BK4588","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4007","SG9999014021.USD","BK4112","LU2210150020.SGD","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628219742","title":"Clearmind Medicine Inc - Cmnd-100 Shows High Safety Profile at Highest Dosage With No Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2628219742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628219742?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:15","pubTimestamp":1776683703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130GP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628427957","title":"Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628427957","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628427957?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:15","pubTimestamp":1776683700,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, April  20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery and development ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276876/0/en/Clearmind-Medicine-Announced-Positive-Top-Line-Safety-Results-CMND-100-Proprietary-Psychedelic-Treatment-Meets-Primary-Endpoint-in-AUD-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627212996","title":"Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627212996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627212996?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:27","pubTimestamp":1776353261,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a primary endpoint achievement, a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-clearminds-cmnd-100-meets-primary-endpoint-in-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-clearminds-cmnd-100-meets-primary-endpoint-in-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627721292","title":"Clearmind announces DSMB recommendation to continue CMND-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627721292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627721292?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:26","pubTimestamp":1776353212,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced Wednesday that its independent Data and Safety Monitoring Board has completed its review and issued a positive ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-announces-dsmb-recommendation-to-continue-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-announces-dsmb-recommendation-to-continue-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627879032","title":"Clearmind advances CMND-100 alcohol use disorder trial, raises dose to 160 mg","url":"https://stock-news.laohu8.com/highlight/detail?id=2627879032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627879032?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:16","pubTimestamp":1776259005,"startTime":"0","endTime":"0","summary":"Clearmind received a positive recommendation from an independent Data and Safety Monitoring Board to continue its FDA-approved Phase I/IIa trial of CMND-100 in patients with moderate to severe Alcohol Use Disorder.Top-line safety results have already been presented internally to the board, showing CMND-100 was well tolerated with no serious adverse events reported.Clearmind will advance to fourth cohort, raising tested dose to 160 mg.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely respons","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL7fBpnc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627579289","title":"Clearmind Medicine Inc - Cmnd-100 Well Tolerated With No Serious Adverse Events in Third Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2627579289","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627579289?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:30","pubTimestamp":1776252600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA9DPH8H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627289547","title":"Clearmind Medicine Inc - to Proceed to Fourth Cohort, Increase Cmnd-100 Dose to 160Mg","url":"https://stock-news.laohu8.com/highlight/detail?id=2627289547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627289547?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:30","pubTimestamp":1776252600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA9DPH8H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627289391","title":"Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in Ongoing Cmnd-100 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627289391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627289391?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:30","pubTimestamp":1776252600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA9DPH8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627899612","title":"Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627899612","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627899612?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:30","pubTimestamp":1776252600,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, April  15, 2026 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery and development","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274332/0/en/Clearmind-Medicine-Announces-Positive-Data-Safety-Monitoring-Board-Recommendation-in-ongoing-CMND-100-clinical-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627421337","title":"Clearmind Medicine issues $1.75 million convertible notes, raises $1.58 million cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2627421337","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627421337?lang=en_us&edition=fundamental","pubTime":"2026-04-15 04:02","pubTimestamp":1776196941,"startTime":"0","endTime":"0","summary":"Clearmind Medicine delivered notice on April 14, 2026 to issue US$ 1.75 million of convertible promissory notes to CLA investors.Purchase price was set at 90% of principal, implying cash proceeds of US$ 1.575 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL3P0QY8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":124,"code":"91000000","status":"200"}]}}